Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 6 II, 2000, Pages 1093-1100

  Kikly, Kristine K ^a   Bochner, Bruce S ^a   Freeman, Sylvie D ^a   Tan, K B ^a   Gallagher, Kathleen T ^a   D'Alessio, Karla J ^a   Holmes, Stephen D ^a   Abrahamson, Julie A ^a   Erickson Miller, Connie L ^b   Murdock, Paul R ^c   Tachimoto, Hiroshi ^d   Schleimer, Robert P ^b   White, John R ^a  

^a Department of Immunology ^*  (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Allergy; Basophil; Cell surface molecule; Eosinophil; Mast cell

Indexed keywords

SIALOADHESIN;

ALLERGY; ARTICLE; BASOPHIL; DIAGNOSTIC VALUE; EOSINOPHIL; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL;

EID: 0033917519     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.107127     Document Type: Article

References (38)

1. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-8.
2. Sur S, Adolphson CR, Gleich GJ. Eosinophil biochemistry and cellular aspects. In: Middleton E, Reed CE, Ellis EF, Adkinson JNF, Yunginger JW, Busse W, editors. Allergy: principles and practice. 4th ed. St Louis: Mosby; 1993. p 169-200.
3. Costa JJ, Weller P, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 1997;278:1815-22.
4. Bochner BS. Cellular adhesion in inflammation. In: Middleton J, Reed C, Ellis E, Adkinson J, Yunginger J, Busse W, editors. Allergy: principles and practice. 5th ed. St Louis: Mosby; 1998. p 94-107.
5. Dahinden CA, Geiser T, Brunner T, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994;179:751-6.
6. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not forneutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995;181:2119-27.
7. Nickel R, Beck L, Stellate C, Schleimer RP. Chemokines and allergic disease. J Allergy Clin Immunol 1999;104:723-42.
8. Romagnani P, DePaulis A, Beltrame C, et al. Tryptase-chymase doublepositive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999;155:1195.
9. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-95.
10. Saito H, Yamada K, Breard J, Yoshie O, Mathe G. A monoclonal antibody reactive with human eosinophils. Blood 1986;67:50.
11. Bodger MP, Mounsey GL, Nelson J, Fitzgerald PH. A monoclonal antibody reacting with human basophils. Blood 1987;69:1414.
12. Zola H. Monoclonal antibodies: a manual of techniques. Boca Raton (FL): CRC Press; 1987.
13. Hansel TT, Vries IMD, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105.
14. Matsumoto K, Appiah-Pippim J, Schleimer RP, Bickel CA, Beck LA, Bochner BS. CD44 and CD69 represent different types of cell surface activation markers for human eosinophils. Am J Respir Cell Mol Biol 1998;18:860.
15. Bochner BS, McKelvey AA, Schleimer RP, Hildreth JEK, MacGlashan DW Jr. Flow cytometric methods for analysis of human basophil surface antigens and viability. J Immunol Methods 1989;125:265.
16. Tachimoto H, Ebisawa M, likura Y, et al. Activated human mast cells release factors supporting eosinophil survival in vitro. Int Arch Allergy Immunol 1997;113:293.
17. Saito H, Ebisawa M, Tachimoto H, et al. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157:343.
18. Strath M, Warren D, Sanderson C. Detection of eosinophils using an eosinophil peroxidase assay: its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985;83:209-15.
19. Collins S. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987;70:1233-44.
20. Macphee CH, Appelbaum ER, Johanson K, et al. Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activity. J Immunol 1998;161:6273-9.
21. Taylor V, Buckley C, Douglas M, Cody A, Simmons D, Freeman S. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem 1999; 274:11505-12.
22. Keim S, Pelz A, Schauer R, et al. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 1994;4:965-72.
23. Freeman SD, Keim S, Barber EK, Crocker PR. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 1995;85:2005-12.
24. Cornish AL, Freeman S, Forbes G, et al. Characterization of Siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 1998;92:2123-32.
25. Vinson M, van der Merwe PA, Keim S, May A, Jones EY, Crocker PR. Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem 1996;271:9267-72.
26. van der Merwe PA, Crocker PR, Vinson M, Barclay AN, Schauer R, Keim S. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem 1996;271:9273-80.
27. Sgroi D, Nocks A, Stamenkovic I. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. J Biol Chem 1996;271:18803-9.
28. Lajaunias F, Ibnou-Zekri N, Jimack L, et al. Polymorphisms in the Cd22 gene of inbred mouse strains. I mmu no genetics 1999;49:991-5.
29. Mayumi M. EoL-1, a human eosinophilic cell line. Leuk Lymphoma 1992;7:243-50.
30. Barnes YC, Skelton TP, Stamenkovic I, Sgroi DC. Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion. Blood 1999;93:1245-52.
31. Razi N, Varki A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sei USA 1999;95:7469-74.
32. Valent P, Majdic O, Maurer D, Bodger M, Muhm M, Bettelheim P. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 1990;91:198-203.
33. Guo C, Kagey-Sobotka A, Lichtenstein L, Bochner B. Immunopheno-typing and functional analysis of purified human uterine mast cells. Blood 1992;79:708-12.
34. Keim S, Schauer R, Crocker PR. The Sialoadhesins - a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily. Glycoconj J 1996;13:913-26.
35. Patel N, Brinkman-Van der Linden ECM, Altmann SW, et al. OBBP1/Siglec-6. J Biol Chem 1999;274:22729-38.
36. Falco M, Biassoni R, Bottino C, et al. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med 1999;190:793-801.
37. Nicoll G, Ni J, Liu D, et al. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J Biol Chem 1999;274:34089-95.
38. Blasioli J, Paust S, Thomas M. Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22. J Biol Chem 1999;274:2302-7.